GeneDx is a biotechnology company based in the USA, founded in 2000, with a workforce of approximately 1,000 employees and reported revenues of $305 million. The company specializes in clinical laboratory services, focusing on genetic testing to aid in the diagnosis of genetic disorders. GeneDx emphasizes the importance of exome and genome testing as first-line diagnostic tools for various conditions, including developmental delays, intellectual disabilities, and congenital anomalies. Their published materials highlight recommendations from professional medical organizations, such as the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors, which endorse these testing methods for individuals with unexplained epilepsy and other genetic concerns. GeneDx's documentation, including checklists for healthcare providers, aims to assist in determining the appropriateness of genetic testing for children exhibiting symptoms associated with genetic conditions. The company's commitment to providing comprehensive genetic insights is evident in its focus on analyzing over 20,000 genes simultaneously to facilitate timely and accurate diagnoses.